Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002419275 | SCV002680010 | pathogenic | Hereditary cancer-predisposing syndrome | 2018-06-12 | criteria provided, single submitter | clinical testing | The c.802_839del38 pathogenic mutation, located in coding exon 5 of the MSH2 gene, results from a deletion of 38 nucleotides at nucleotide positions 802 to 839, causing a translational frameshift with a predicted alternate stop codon (p.S268Ifs*3). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |